Angiogenesis Inhibitors: all 4,430 studies that test it

Page 18 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerCompletedNCT00478426Phase 2Results posted
• Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00478218Phase 2Results posted
• Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00477750Phase 1/2Results posted
• A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasCompletedNCT00474994Phase 2Results posted
• A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaTerminatedNCT00474188Phase 2Results posted
• A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)CompletedNCT00473590Phase 2Results posted
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)CompletedNCT00473382Phase 3Results posted
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)CompletedNCT00473330Phase 3Results posted
• Efficacy And Safety Of Sunitinib In Women With Advanced Breast CancerCompletedNCT00471276Phase 2Results posted
• Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical ModelCompletedNCT00468585Phase 1/2Results posted
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00467142Phase 2Results posted
• Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary SyndromeCompletedNCT00466921Phase 2Results posted
• Erlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaCompletedNCT00466687Phase 2Results posted
• Sunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerCompletedNCT00465179Phase 2Results posted
• Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerCompletedNCT00464646Phase 2Results posted
• A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid MetaplasiaCompletedNCT00463385Phase 2Results posted
• Sutent and Radiation as Treatment for Limited Extent Metastatic CancerCompletedNCT00463060Phase 1/2Results posted
• Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaCompletedNCT00462982Phase 2Results posted
• Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseTerminatedNCT00462865Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00462826Phase 2Results posted
• Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00462501Not applicableResults posted
• Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II StudyCompletedNCT00462423Phase 2Results posted
• Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00460031Phase 2Results posted
• Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryCompletedNCT00459979Phase 2Results posted
• Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00459875Phase 2Results posted
• Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple MyelomaCompletedNCT00458705Phase 2Results posted
• A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)CompletedNCT00457743Phase 1/2Results posted
• Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerCompletedNCT00457691Phase 3Results posted
• A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneCompletedNCT00457392Phase 3Results posted
• Effect of Ranibizumab on Malignant Conjunctival NeoplasiaCompletedNCT00456495Phase 1Results posted
• High-dose Bevacizumab in Advanced Renal Carcinoma PatientsCompletedNCT00455975Phase 2Results posted
• Sunitinib in Refractory Adrenocortical CarcinomaCompletedNCT00453895Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00453154Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.CompletedNCT00451906Phase 4Results posted
• Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaCompletedNCT00451048Phase 2Results posted
• R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00450255Phase 2Results posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal CancerTerminatedNCT00449163Phase 2Results posted
• FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedNCT00448019Phase 2Results posted
• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerCompletedNCT00445848Phase 2Results posted
• Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple MyelomaCompletedNCT00445692Phase 2Results posted
• Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00445484Phase 2Results posted
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyCompletedNCT00445003Phase 3Results posted
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaCompletedNCT00444600Phase 3Results posted
• Lapatinib and Bevacizumab for Metastatic Breast CancerCompletedNCT00444535Phase 2Results posted
• A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.CompletedNCT00443534Not applicableResults posted
• Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00442507Phase 2Results posted
• Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00439231Phase 2Results posted
• Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00438204Phase 2Results posted
• Aflibercept for Relapsed Multiple MyelomaTerminatedNCT00437034Phase 2Results posted
• S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 2Results posted
• Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal CancerCompletedNCT00436215Phase 2Results posted
• A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerCompletedNCT00435409Phase 3Results posted
• A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube CarcinomaCompletedNCT00434642Phase 3Results posted
• A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)TerminatedNCT00434356Phase 2Results posted
• A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic MelanomaCompletedNCT00434252Phase 2Results posted
• A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)TerminatedNCT00434226Phase 2Results posted
• Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerActive, not recruitingNCT00433511Phase 3Results posted
• Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple MyelomaCompletedNCT00432458Phase 3Results posted
• Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) PatientsCompletedNCT00428922Phase 2Results posted
• A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsTerminatedNCT00428597Phase 3Results posted
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
• A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00424047Phase 3Results posted
• Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00423930Phase 2Results posted
• Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00423917Phase 2Results posted
• Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular DegenerationTerminatedNCT00423189Phase 4Results posted
• A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00420849Phase 3Results posted
• SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialCompletedNCT00418938Phase 2Results posted
• Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian CarcinomaTerminatedNCT00418093Phase 2Results posted
• Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas CancerCompletedNCT00417976Phase 2Results posted
• A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast CancerTerminatedNCT00417885Phase 1/2Results posted
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00416494Phase 2Results posted
• A Study of Revlimid in the Treatment of Non-Hodgkin's LymphomaCompletedNCT00413036Phase 2Results posted
• Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With GliomasCompletedNCT00412542Phase 2Results posted
• Efficacy and Safety of Sunitinib in Metastatic Gastric CancerCompletedNCT00411151Phase 2Results posted
• Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00410956Phase 2Results posted
• Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple MyelomaCompletedNCT00410605Phase 2Results posted
• A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00409565Phase 2Results posted
• Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal CancerCompletedNCT00408694Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00408408Phase 3Results posted
• Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT00408070Phase 2Results posted
• VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00407654Phase 2Results posted
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal CancerCompletedNCT00407563Phase 2Results posted
• VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the UrotheliumCompletedNCT00407485Phase 2Results posted
• The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) StudyCompletedNCT00407381Phase 2Results posted
• A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.CompletedNCT00405756Phase 3Results posted
• A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)CompletedNCT00403403Phase 2Results posted
• Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNCT00403169Phase 2Results posted
• Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast CancerCompletedNCT00403130Phase 2Results posted
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung CancerTerminatedNCT00402883Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung CancerCompletedNCT00400803Phase 2Results posted
• Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaCompletedNCT00400569Phase 2Results posted
• GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate CancerCompletedNCT00400517Phase 2Results posted
• Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsCompletedNCT00398320Phase 2Results posted
• Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00398112Phase 2Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT00397982Phase 2Results posted

← Angiogenesis Inhibitors overview